Fentanyl

Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

Retrieved on: 
Tuesday, April 2, 2024
Narcotic, Certification, Astrotech, Conference, Heroin, Cocaine, ETD, International, Law enforcement, NTD, Prison, European Civil Aviation Conference, Exposition, Astrotech Corporation, Airport, Mass spectrometry, ASTC, TRACER, Fentanyl, Drug

The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).

Key Points: 
  • The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).
  • Currently, the Company’s Tracer 1000 ETD is now found in multiple locations in 14 countries throughout the world.
  • “We are extremely excited to share our user-friendly mass spectrometer the TRACER 1000, which is powered by our AMS Technology, with leading industry experts and security industry professionals at the ISC West conference.
  • The TRACER 1000 is the first mass spectrometry-based ETD to have received European Civil Aviation Conference (“ECAC”) certification for both checkpoint and cargo security.

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

Retrieved on: 
Thursday, March 28, 2024
FSA, U.S. FDA, Arm, Heroin, Risk, Education, Pharmacy, School, Naloxone, Policy, EBS, Flexible, House, Drug, OTC, CDC, Restaurant, Medicaid, National Safety Council, AED, HSA, FDA, Emergent BioSolutions, NSC, Medicine, Fentanyl, Pharmaceutical industry

Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.

Key Points: 
  • Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.
  • Since the OTC launch, NARCAN® Nasal Spray can be purchased at more than 32,000 mass drug, grocery, online retailers and e-commerce sites.
  • Emergent is working with retail partners to make it easy to find and access, however each retailer ultimately determines in-store product placement.
  • “That’s why we remain committed to increasing awareness of NARCAN® Nasal Spray availability.

FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose

Retrieved on: 
Monday, April 8, 2024
General Health, FDA, Health, Pharmaceutical, Medical Supplies, Hypoventilation, Hypersensitivity, Nalmefene, Pulmonary edema, Caregiver, Safety, Tachycardia, Risk, New Drug Application, Patient, Ventricular tachycardia, Naloxone, Health care, Buprenorphine, Mortality, NDA, MD, Methadone, Ventricular fibrillation, Hypotension, Oxygen, LAAM, Recurrence, Allergy, Purdue University, Hypertension, Fentanyl, Pharmaceutical industry

Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.

Key Points: 
  • Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.
  • "Through this auto-injector FDA submission, our goal is to help expand the availability of nalmefene to the community alongside existing available options for healthcare professionals.
  • Priority review status means that FDA will expedite the review process to evaluate a drug that would significantly improve treatment of a serious condition.
  • Nalmefene Hydrochloride Injection is indicated in the management of known or suspected opioid overdose.

Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

Retrieved on: 
Monday, March 25, 2024
Astrotech, Conference, Heroin, Cocaine, ETD, Law enforcement, NTD, Prison, European Civil Aviation Conference, Airport, Mass spectrometry, ASTC, TRACER, Fentanyl, Drug

The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds.

Key Points: 
  • The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds.
  • Currently, the Company’s Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world.
  • The Astrotech Mass Spectrometer Technology™ (AMS Technology) drives the breakthrough TRACER 1000, as the first certified ETD to employ mass spectrometry as a trace detection security solution.
  • The TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference certification for both checkpoint and cargo security.

New Poll Shows Arizonans Want Action on Homelessness

Retrieved on: 
Monday, March 18, 2024
Homelessness, Crime, Sanitation, Camping, Business, Public policy, Smash, Fentanyl, City, Restaurant, Water, Illegal drug trade, Police

"Arizonans want leaders to respond with urgency as crime, drugs, and homelessness in their communities continue to rise.

Key Points: 
  • "Arizonans want leaders to respond with urgency as crime, drugs, and homelessness in their communities continue to rise.
  • Author of the poll and Cicero Director of Communications Stefani Buhajla added, "These results are not at all surprising.
  • Arizona has been battling crisis levels of drug trafficking and homelessness for years.
  • Key highlights from the survey:
    Addressing Homelessness: The survey highlights significant concerns regarding homelessness, with 74% of all voters believing it is increasing in Arizona.

Methamphetamine Use in Arizona Reaches All-Time High in People Who Use Fentanyl, Adding Fuel to the Fentanyl Crisis

Retrieved on: 
Wednesday, April 3, 2024
Public Policy, Government, Health, State, Local, Other Health, General Health, Pharmaceutical, Methamphetamine, Multimedia, Fentanyl, Drug

Coming off the heels of the recent $850 million in funding secured to prevent fentanyl from entering Arizona1 and as the state continues to grapple with this ongoing crisis, a dangerous trend in the co-use of methamphetamine has emerged that may significantly impact an already challenging situation.

Key Points: 
  • Coming off the heels of the recent $850 million in funding secured to prevent fentanyl from entering Arizona1 and as the state continues to grapple with this ongoing crisis, a dangerous trend in the co-use of methamphetamine has emerged that may significantly impact an already challenging situation.
  • According to Millennium Health’s Signals Report™ for Arizona, a staggering 79% of urine drug test specimens collected in 2023 from those who used fentanyl also contained methamphetamine, an increase of 2,024% since 2013.
  • This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20240403924990/en/
    Methamphetamine positivity rates among people who use fentanyl for five of the most-populated counties in 2023 were:

Methamphetamine Use in California Reaches All-Time High in People Who Use Fentanyl, Adding Fuel to the Fentanyl Crisis

Retrieved on: 
Wednesday, March 20, 2024
Mental Health, Men, Law Enforcement, Emergency Services, General Health, Public Policy, Government, Hospitals, Millennials, Nursing, Consumer, Health, Public Safety, Generation Z, State, Local, Generation X, Other Health, Teens, Women, Methamphetamine, Multimedia, Fentanyl, Drug

In 2023, a record 62,224 pounds of fentanyl were seized in California, an increase of 1,066% since 2021 – enough fentanyl to potentially kill the global population nearly twice over1.

Key Points: 
  • In 2023, a record 62,224 pounds of fentanyl were seized in California, an increase of 1,066% since 2021 – enough fentanyl to potentially kill the global population nearly twice over1.
  • While the state continues to grapple with this ongoing crisis, a dangerous trend in the co-use of methamphetamine has emerged that may significantly impact an already challenging situation.
  • According to Millennium Health’s Signals Report™ for California, a staggering 72% of urine drug test specimens collected in 2023 from those who used fentanyl also contained methamphetamine, an increase of 2,235% since 2013.
  • View the full release here: https://www.businesswire.com/news/home/20240320277270/en/
    Methamphetamine positivity rates among people who use fentanyl for seven of the most-populated counties in 2023 were:

Methamphetamine Use in Washington Reaches All-Time High in People Who Use Fentanyl, Adding Fuel to the Fentanyl Crisis

Retrieved on: 
Wednesday, March 13, 2024
Science, Public Policy, Government, Other Science, Pharmaceutical, State, Local, General Health, Health, Public Safety, Methamphetamine, Multimedia, Doctor of Pharmacy, CPE, Fentanyl, Drug

While the state of Washington grapples with its ongoing fentanyl crisis, a dangerous trend in the co-use of methamphetamine has emerged that may significantly impact an already challenging situation.

Key Points: 
  • While the state of Washington grapples with its ongoing fentanyl crisis, a dangerous trend in the co-use of methamphetamine has emerged that may significantly impact an already challenging situation.
  • According to Millennium Health’s Signals Report™ for Washington state, a staggering 76% of urine drug test specimens collected in 2023 from those who used fentanyl also contained methamphetamine, an increase of over 8,000% since 2013.
  • This new data brings to light an urgent need to find solutions to this growing crisis.
  • I am confident that we can work together to help to stem this tide that is destroying our families and our local communities.”

CHLA Researchers Find That Length of Opioid Treatment for Hospitalized Infants Differs by Institution and Geography

Retrieved on: 
Tuesday, March 12, 2024
Other Health, Research, Pharmaceutical, Family, Consumer, Hospitals, Children, Science, Surgery, Baby, Maternity, Other Science, Health, JAMA Network Open, Ventricular septal defect, Risk, Infant, Prescription, MD, Methadone, MSHS, Hydromorphone, Morphine, Multimedia, Paper, Policy, Intubation, Fentanyl

View the full release here: https://www.businesswire.com/news/home/20240312681130/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240312681130/en/
    In a study published in JAMA Network Open, researchers at Children’s Hospital Los Angeles found the opioid treatment that critically ill, hospitalized infants received depended on their location.
  • The length of time the infants were prescribed opioids differed by geographic region across the U.S.— the Northeast, South, Midwest or West.
  • “Additionally, prolonged opioid exposure in high-risk hospitalized infants has been implicated in worsening neurodevelopmental outcomes,” Dr. Keane says.
  • During their hospital stay, 76% of infants were prescribed opioids such as fentanyl, morphine and hydromorphone, and about 8% received methadone.

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health on the Overdose Crisis

Retrieved on: 
Wednesday, March 27, 2024
Health, Friends, Public, Law enforcement, History, Death, Infection, Housing, CDSS, Harm reduction, Emergency medical services, EMS, Xylazine, Government, Fentanyl, Nursing

The overdose crisis is tragic and having devastating impacts on individuals, friends, and families across the country, leaving no community left untouched.

Key Points: 
  • The overdose crisis is tragic and having devastating impacts on individuals, friends, and families across the country, leaving no community left untouched.
  • Today's national data release on opioid-and stimulant-related harms shows us that the number of opioid-related deaths in Canada remains far too high.
  • An average of 22 people are dying every day, and there are approximately 80 opioid-related poisoning emergency department visits per day.
  • Additionally, from January to September 2023, there were 33,015 Emergency Medical Services (EMS) responses for suspected opioid-related overdoses.